Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayan Bou-Fakhredin

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Blood Transfusion = Trasfusione Del Sangue|October 25, 2021
Advancing the care of β-thalassaemia patients with novel therapiesRayan Bou-Fakhredin, Irene Motta, Maria Domenica Cappellini
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2018
Deferasirox: Over a Decade of Experience in ThalassemiaNour M Moukalled, Rayan Bou-Fakhredin, Ali T Taher
Expert Review of Hematology|July 14, 2017
Insights into the diagnosis and management of iron deficiency in inflammatory bowel diseaseRayan Bou-Fakhredin, Racha Halawi, Joseph Roumi, et al.
Expert Review of Hematology|November 22, 2022
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal careNour M Moukalled, Rayan Bou Fakhredin, Ali T Taher
Expert Opinion on Emerging Drugs|April 7, 2020
Emerging therapies in β-thalassemia: toward a new era in managementRayan Bou-Fakhredin, Rami Tabbikha, Hisham Daadaa, et al.
The Lancet. Haematology|May 25, 2024
Step out of the shadows: a call for action for rare diseasesFrancesca Granata, Rayan Bou-Fakhredin, Maria Domenica Cappellini, et al.
Hematology/Oncology Clinics of North America|March 12, 2023
Emerging Therapies in β-ThalassemiaRayan Bou-Fakhredin, Kevin H M Kuo, Ali T Taher
Drugs|June 20, 2020
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron ChelationIrene Motta, Rayan Bou-Fakhredin, Ali T Taher, et al.
Hematology (Amsterdam, Netherlands)|June 8, 2017
Revisiting beta thalassemia intermedia: past, present, and future prospectsNaouel Ben Salah, Rayan Bou-Fakhredin, Fethi Mellouli, et al.
Minerva Medica|August 3, 2023
Beta-thalassemia: is cure still a dream?Mohammad H Hodroj, Nathalie Akiki, Rayan Bou-Fakhredin, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Blood Transfusion = Trasfusione Del Sangue|October 25, 2021
Advancing the care of β-thalassaemia patients with novel therapiesRayan Bou-Fakhredin, Irene Motta, Maria Domenica Cappellini
Mediterranean Journal of Hematology and Infectious Diseases|November 13, 2018
Deferasirox: Over a Decade of Experience in ThalassemiaNour M Moukalled, Rayan Bou-Fakhredin, Ali T Taher
Expert Review of Hematology|July 14, 2017
Insights into the diagnosis and management of iron deficiency in inflammatory bowel diseaseRayan Bou-Fakhredin, Racha Halawi, Joseph Roumi, et al.
Expert Review of Hematology|November 22, 2022
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal careNour M Moukalled, Rayan Bou Fakhredin, Ali T Taher
Expert Opinion on Emerging Drugs|April 7, 2020
Emerging therapies in β-thalassemia: toward a new era in managementRayan Bou-Fakhredin, Rami Tabbikha, Hisham Daadaa, et al.
The Lancet. Haematology|May 25, 2024
Step out of the shadows: a call for action for rare diseasesFrancesca Granata, Rayan Bou-Fakhredin, Maria Domenica Cappellini, et al.
Hematology/Oncology Clinics of North America|March 12, 2023
Emerging Therapies in β-ThalassemiaRayan Bou-Fakhredin, Kevin H M Kuo, Ali T Taher
Drugs|June 20, 2020
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron ChelationIrene Motta, Rayan Bou-Fakhredin, Ali T Taher, et al.
Hematology (Amsterdam, Netherlands)|June 8, 2017
Revisiting beta thalassemia intermedia: past, present, and future prospectsNaouel Ben Salah, Rayan Bou-Fakhredin, Fethi Mellouli, et al.
Minerva Medica|August 3, 2023
Beta-thalassemia: is cure still a dream?Mohammad H Hodroj, Nathalie Akiki, Rayan Bou-Fakhredin, et al.
Pageof 5